Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HELIVAC

Financiado

Cerrado

Overpowering helminth mediated immune modulation is a route towards vaccine deve...

Overpowering helminth mediated immune modulation is a route towards vaccine development against these major animal pathogens "Helminth (worm) pathogens cause >55% of all animal diseases which result in enormous losses to the global agricultural economy. Since the use of chemical products to treat worms is not sustainable in the long term because of the... ver más

31/05/2018

THE QUEEN'S UNIVER...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

THE QUEENS UNIVERSITY OF BELFAST No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2018-05-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

THE QUEEN'S UNIVERSITY OF BE...

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AGL2015-68477-P AGONISTAS DE RECEPTORES TOLL-LIKE (TLRS) COMO INMUNOTERAPIA... 208K€ Cerrado

BES-2014-068148 MECHANISMS OF INFECTED CELL RECOGNITION AND IN VIVO CONTROL... 88K€ Cerrado

APATRIVAP Antigen processing and T cell recognition of intravacuolar p... 100K€ Cerrado

SAF2010-15074 VEHICULIZACION DE ANTIGENOS A LAS CELULAS DENDRITICAS PARA M... 121K€ Cerrado

PID2019-110407RB-I00 ESTIMULACION DE LA MEMORIA INMUNOLOGICA Y DE LA PRESENTACION... 194K€ Cerrado

Paragone PARAGONE vaccines for animal parasites 9M€ Cerrado

Líder del proyecto

THE QUEENS UNIVERSITY OF BELFAST No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Helminth (worm) pathogens cause >55% of all animal diseases which result in enormous losses to the global agricultural economy. Since the use of chemical products to treat worms is not sustainable in the long term because of the continual emergence of drug-resistant parasites and consumer concerns about what they eat, control by vaccines is the most appropriate way forward. However, there are presently no vaccines for any animal or human helminth pathogen. We hypothesise that the ability of helminth parasites to suppress the protective arm of the immune response explains why we have been unsuccessful in developing efficacious vaccines against these pathogens. During helminth infection the function of innate immune cells, dendritic cells (DCs) and macrophages, is manipulated by the parasite to create a T helper (Th) cell 2-driven immune response that is beneficial to its survival, while simultaneously suppressing the immunoprotective Th1-driven response. This helminth-induced immune modulation is induced by the secretion of specific parasite immunomodulatory molecules. Focusing on the helminth that causes animal and human fascioliasis (liver fluke disease), we will ‘turn-the-table’ on this parasite by targeting its immunomodulatory mechanisms and develop vaccine formulations that induce potent protective Th1-inducing humoral and cellular immune responses. The project involves both innovative and discovery approaches in the search for novel helminth immunomodulatory molecules, and a translational element that will bring these findings into a useful veterinary medicine application for the end-users, farmers and consumers. The breakthrough of this project, therefore, will not only be the development of a vaccine against liver fluke disease, but also the opening of a new route towards the control of many other major helminth pathogens of both animals and humans."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores